NewslettersImmunology of Infectious Disease NewsUncategorizedWeak Immunogenicity of SARS-CoV-2 Vaccine in Patients with Hematologic MalignanciesBy Justin.choi - August 10, 2021011The authors evaluated the safety and immunogenicity of BNT162b2 vaccine in patients with hematological malignancies.[Blood Cancer Journal] 6445218 AX28WCQW items 1 apa 0 default asc 1 165525 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full Article